Sustainable Development for the Healthcare Industry Reprogramming the Healthcare Value Chain /

This volume addresses the dynamics of sustainable development in the healthcare industry, covering all major aspects of the industry, including R&D, manufacturing, regulation, market access, commercialization, and general management.  Healthcare markets are evolving under demographic and economi...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Morgon, Pierre A. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2015.
Σειρά:Perspectives on Sustainable Growth,
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 06376nam a22005295i 4500
001 978-3-319-12526-8
003 DE-He213
005 20151204180830.0
007 cr nn 008mamaa
008 141213s2015 gw | s |||| 0|eng d
020 |a 9783319125268  |9 978-3-319-12526-8 
024 7 |a 10.1007/978-3-319-12526-8  |2 doi 
040 |d GrThAP 
050 4 |a RA971.3-971.32 
072 7 |a KCQ  |2 bicssc 
072 7 |a MED002000  |2 bisacsh 
082 0 4 |a 362.10681  |2 23 
245 1 0 |a Sustainable Development for the Healthcare Industry  |h [electronic resource] :  |b Reprogramming the Healthcare Value Chain /  |c edited by Pierre A. Morgon. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2015. 
300 |a X, 154 p. 14 illus., 8 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Perspectives on Sustainable Growth,  |x 2199-8566 
505 0 |a Ch 1 Sustainable development for the healthcare industry: Setting the stage -- Ch 2 Can innovation still be the main growth driver of the pharmaceutical industry? -- Ch 3 The importance of understanding the 'lived experience' of patients in pharmaceutical development programs -- Ch 4 Listening to the voice of the patient to facilitate earlier access to promising medicines: Interview with Sjaak Vink -- Ch 5 Drivers of the Real World Data revolution and the transition to Adaptive Licensing: Interview with Dr. Richard Barker -- Ch 6 Sustainable development for the healthcare industry: Vantage Point from Emerging Economies -- Ch 7 Disease Management in the perspective of sustainable growth in heath care system -- Ch 8 Thoughts on Sustainable Healthcare...in a Patient-Centric Society -- Ch 9 The Biopharmaceutical Industry as part of the solution for healthier, wealthier societies: Interview with Dr. Eduardo Pisani -- Ch 10 Sustainable development initiatives: Examples of successful programs and lessons learned-Interview with Dr. François Bompart -- Ch 11 The challenges of Sustainable Development for the Healthcare Industry: An Examination from the Perspectives of Biomedical Enterprises -- Ch 12 Corporation's social responsibility: From the awareness of philanthropy to the demand of implementation-The Case of Expanscience. 
520 |a This volume addresses the dynamics of sustainable development in the healthcare industry, covering all major aspects of the industry, including R&D, manufacturing, regulation, market access, commercialization, and general management.  Healthcare markets are evolving under demographic and economic pressures. In mature markets, patients navigate highly complex provider and cash-strapped payer systems with limited control on healthcare quality and outcomes (as reflected by the absence of correlation between spending and patient satisfaction and outcomes). In developing markets, patients have limited awareness, access and ability to pay for healthcare. The pools of profit will progressively shift from prescription drugs to other product segments and to healthcare delivery, and these shifts will be different by region. As it is dealing with a R&D drought, a revenues deflation induced by patient expiries affecting primary care franchises, a portfolio mix evolution towards specialty care products designed for highly profiled patient populations and backed by complex scientific and medical data, the industry needs to identify which business targets are genuinely attractive for major or new investments.   At the same time, development of new products and services must be tackled within the context of environmental sustainability.  Rather than focusing on the traditional issues of innovation, cost management, and commercial effectiveness associated with growth, the authors—including leading academics and industry insiders—explore such emerging topics as: The mutations of the management of innovation, as it remains the DNA of the healthcare industry, driven by patient focus and the trend towards personalized medicine the need to foster patient-centricity along the entire value chain of the healthcare industry and company-wide, starting by listening to the voice of the patient earlier in the lifecycle of drug candidates the broad scope of issues related to improving access to care and disease management, from drug design, to innovative licensing, to valuation based on real-world evidence, to supply and availability so as to ensure optimal access the allocation of educational resources focused on the patient to increase the effectiveness of disease management the preservation of natural resources and the environmental effects of pollution and hazards created by the handling of pharmaceutical products the capacity issues in relation to the size of the medical need and/or of the market demand the private-public partnerships to address the full spectrum of public health issues, from basic patient access to care to managing global health crises, the required organizational and governance evolutions for the healthcare industry to maintain profitable and sustainable growth.   Emphasizing environmental, economically, and socially sustainable practices, the authors present a unique, multi-faceted set of perspectives on this vital and rapidly evolving field. They provide a unique vantage point on the reboot the healthcare industry should engage into in order to enhance the sustainability of its business model. 
650 0 |a Business. 
650 0 |a Management. 
650 0 |a Industrial management. 
650 0 |a Production management. 
650 0 |a Health care management. 
650 0 |a Health services administration. 
650 0 |a Sustainable development. 
650 1 4 |a Business and Management. 
650 2 4 |a Health Care Management. 
650 2 4 |a Operations Management. 
650 2 4 |a Innovation/Technology Management. 
650 2 4 |a Sustainable Development. 
700 1 |a Morgon, Pierre A.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319125251 
830 0 |a Perspectives on Sustainable Growth,  |x 2199-8566 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-12526-8  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBE 
950 |a Business and Economics (Springer-11643)